Results From Largest Statin Study Of Patients With Alzheimer’s Disease Show Lipitor(R) Has No Significant Impact On Disease
In a study in patients with mild-to-moderate Alzheimer’s disease (AD), the addition of Lipitor (atorvastatin calcium tablets) 80 mg to Aricept® (donepezil HCl) 10 mg showed no significant differences in cognition or global function (key measures of Alzheimer’s progression) compared to placebo plus Aricept 10 mg. Furthermore, no statistically significant differences were seen on various cognitive, behavioral and functional secondary endpoints.
More: continued here
Filed under: Alzheimer's / Dementia News XML/RSS Feed on April 22nd, 2008